Shanghai RNACure Biopharma Co., Ltd.
PrivateLast Round
Series A
Extension
May 23, 2022
Company Overview
Shanghai RNACure Biopharma Co., Ltd. is a biotechnology company that develops mRNA-based vaccines and therapeutic platforms for infectious diseases, immuno-oncology, and rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai RNACure Biopharma Co., Ltd. Comparables
Compare Shanghai RNACure Biopharma Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Innovac Therapeutics | 86% | |
| RNAimmune | 84% | |
| WestGene Biopharma | 84% | |
Shanghai RNACure Biopharma Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | May 23, 2022 | ||||
| Series A | Sep 27, 2021 | ||||
| Pre Seed | Mar 29, 2021 | ||||
| Angel | Jan 11, 2021 |
Shanghai RNACure Biopharma Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bencao Capital | Series A |
| Guoke Jiahe Capital | Pre Seed |
| Shine Asset | Series A |
| CoStone Capital | Series A Extension |
| LYZZ Capital | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 23, 2022
CoStone Capital and China State-Owned Capital Venture Investment Fund participated.
- Mar 29, 2021
Raised capital from Guoke Jiahe Capital and LYZZ Capital.
Shanghai RNACure Biopharma Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Shanghai RNACure Biopharma Co., Ltd.'s valuation, stock price, and market status.